戻る Agenda
Session 2: Patient Centric Labeling for Shared Decision-making in Healthcare
Session Chair(s)
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan
Brandon Stempo
Practice Leader Regulatory Labeling
Opus Regulatory Inc, United States
Nowadays patients often search for product information online, where they may encounter inaccurate and outdated information, since the sources are not always reliable. To empower patients to be active participants in their healthcare plan and enable shared decisions with their healthcare providers, it is essential to develop patient-centric labeling that prioritizes health literacy. This session will explore the patient needs for product information and discuss the best practices for developing patient-centric labeling that incorporates health literacy principles. In addition, this session will also highlight the importance for leveraging digital labeling initiatives to enhance patient access to reliable information in a patient friendly method.
Learning Objective : - Discuss the components and best practices for incorporating health literacy testing into labeling
- Describe the strategies for effective utilization of digital patient labeling
- Identify the current challenges in ensuring patients receive accurate and accessible information through active patient participation and digital initiatives
Speaker(s)
Speaker
Marva Schodel, MBA, MS
Merck & Co., United States
Senior Director of Regulatory Affairs, Global Labeling Therapeutic Area Lead, an
Speaker
Karel Martinus van der Waarde, PhD, MA
Lucerne University of Applied Sciences and Arts, Switzerland
Lecturer
Speaker
Yuri Quintana, PhD
Beth Israel Deaconess Medical Center, United States
Chief, Division of Clinical Informatics